News | Radiation Oncology | May 18, 2021

Comprehensive approach to complex cases enables broad access to exceptional medical expertise from world-renowned specialists at Cleveland Clinic

The Clinic by Cleveland Clinic, a transformative joint venture between Cleveland Clinic and Amwell that aligns world-class clinical expertise with the power of innovative digital health technologies, announced that its virtual second opinion solution, available to health plans, employers and consumers, will now include multidisciplinary case analysis.

May 18, 2021 — The Clinic by Cleveland Clinic, a transformative joint venture between Cleveland Clinic and Amwell that aligns world-class clinical expertise with the power of innovative digital health technologies, announced that its virtual second opinion solution, available to health plans, employers and consumers, will now include multidisciplinary case analysis. The Clinic’s virtual second opinion offering provides patients, including those with complex medical conditions, the ability to obtain support from Cleveland Clinic’s world-renowned multidisciplinary panels, whose diversity of expertise ensures the most comprehensive and coordinated second opinion and treatment plan is offered.

“We chose to enter into the multi-disciplinary opinion space by offering services for brain tumor and prostate cancers because there are multiple treatment options for these patients,” said Peter Rasmussen, M.D., Chief Clinical Officer with The Clinic. “Given that these cancers can be treated with surgery, chemotherapeutics, and/or several different types of radiation, one physician isn't able to deliver a holistic opinion. Only multiple physicians from multiple specialties can provide the best recommendation to yield the highest quality of care and thereby the best value care. Our goal is to give patients access to Cleveland Clinic’s vast medical expertise from a variety of different perspectives for the best patient outcomes.”

According to a study published by the National Institutes of Health, more than 40% of cancer patients seeking a second opinion had a change in diagnosis as a result of multidisciplinary panel review, while 23% of patients were determined to present with additional, previously-undiagnosed cancers.

Added Frank McGillin, CEO of The Clinic, “Pairing patients who have complex medical conditions with coordinated support for multidisciplinary review reduces the risk of suboptimal treatment plans. It also protects them from higher-than-necessary healthcare expenses while providing peace of mind that they’re on the right path. For employers and health plans, the right diagnosis and treatment equates to better member outcomes and reduced costs of care.”

For more information: www.theclinic.io


Related Content

News | Women's Health

Nov. 3, 2025 — —A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 ...

Time November 04, 2025
arrow
News | X-Ray

Oct. 30, 2025 – In collaboration with OBIO, University Health Network (UHN), Canada’s leading hospital and the No. 1 ...

Time November 03, 2025
arrow
News | Magnetic Resonance Imaging (MRI) | Children's Hospital Los Angeles

Oct. 28, 2025 — Bronchopulmonary dysplasia (BPD) is the most common — and most serious — complication of extreme ...

Time October 31, 2025
arrow
News | FDA

Oct. 30, 2025 — Sirona Medical has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Sirona ...

Time October 30, 2025
arrow
Feature | Archive Cloud Storage | Shujah Dasgupta, Vice President, CitiusTech

Almost two-thirds of health systems are already using (or plan to use) the cloud for storing and viewing medical images ...

Time October 30, 2025
arrow
News | Cardiac Imaging

Oct., 2025 — Elucid, an AI medical technology company focused on providing physicians with a more precise view of ...

Time October 29, 2025
arrow
News | Radiology Business | Harvey L. Neiman Health Policy Institute

Oct. 27, 2025 — A new study from the Harvey L. Neiman Health Policy Institute found that radiologists who experienced ...

Time October 28, 2025
arrow
News | Endoscopes

Oct. 22, 2025 — Fujifilm Healthcare Americas Corp. has launched its advanced endoscopy platform, the ELUXEO 8000 ...

Time October 23, 2025
arrow
News | X-Ray

Oct. 22, 2025 — Imaging technology company Adaptix has begun live imaging trials as part of a research program at the ...

Time October 22, 2025
arrow
Feature | Kyle Hardner

Radiotherapy contributes to about 40% of all cancer cures but still lags behind systemic therapy in funding and ...

Time October 21, 2025
arrow
Subscribe Now